1.
Immunotargets Ther
; 2: 39-49, 2013.
Article
in English
| MEDLINE
| ID: mdl-27471687
ABSTRACT
This overview provides an analysis of some of the immunotherapies currently in use and under investigation, with a special focus on the tumor microenvironment, which we believe is a major factor responsible for the general failure of immunotherapy to date. It is our expectation that combining immunotherapy with methods of altering the tumor microenvironment and targeting regulatory T cells and myeloid cells will yield favorable results.